Table 6 Comparison of sites of disease... | American Society of Hematology

Table 6

Comparison of sites of disease and laboratory findings between the present series and those of Ferreri et al²⁰

	Present series	Ferreri et al²⁰	P
No. of patients	96	38	—
B symptoms, %	76	55	.018
Sites of disease, %
Bone marrow	75	32	< .001
Spleen	67	26	< .001
Liver	55	26	.003
Peripheral blood	24	5	.012
Central nervous system	27	39	.171
Skin	15	39	.002
Lymph nodes	11	11	> .999
Laboratory findings, %
Anemia, less than 120 g/L hemoglobin*	78	63	.075
Thrombocytopenia, less than 150 × 10⁹/L	76	29	< .001
Serum LDH level, high†	93	86	.278
Hypoalbuminemia: less than 36 g/L	84	18	< .001

	Present series	Ferreri et al²⁰	P
No. of patients	96	38	—
B symptoms, %	76	55	.018
Sites of disease, %
Bone marrow	75	32	< .001
Spleen	67	26	< .001
Liver	55	26	.003
Peripheral blood	24	5	.012
Central nervous system	27	39	.171
Skin	15	39	.002
Lymph nodes	11	11	> .999
Laboratory findings, %
Anemia, less than 120 g/L hemoglobin*	78	63	.075
Thrombocytopenia, less than 150 × 10⁹/L	76	29	< .001
Serum LDH level, high†	93	86	.278
Hypoalbuminemia: less than 36 g/L	84	18	< .001

— indicates not applicable.

Values for this term are based on the definition by Ferreri et al.²⁰

Higher than the upper limit of the standard range defined by each institution.